micafungin Type of group

2 trials

Sponsors

FUJISAWA HEALTH CARE INC,

Early Phase 1

COMPARATIVE STUDY OF PHASE 3, RANDOMIZED, DOUBLE BLIND MICAFUNGIN (FK463) VERSUS FLUCONAZOL FOR THE TREATMENT OF CANDIDIASIS ESOFAGITIS

Active, not recruitingPER-036-03

FUJISAWA HEALTH CARE INC,

Target: 19Updated: 2023-09-04

Unknown Phase

Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis.

Active, not recruitingPER-055-03

FUJISAWA HEALTH CARE INC,

Updated: 2023-09-04